about
Selective serotonin re-uptake inhibitors and the risk of bleedingDiarrhea, negative t-waves, fever and skin rash, rare manifestation of carbamazepine hypersensitivity: a case report.Clozapine-induced blood dyscrasias in Saudi Arab patients.Are clozapine blood dyscrasias associated with concomitant medications?Interferon-induced depression in hepatitis C: an update.Haematological toxicity of drugs used in psychiatry.Clozapine reinitiation following a "red result" secondary to chemotherapy.The autophagy-inducing drug carbamazepine is a radiation protector and mitigatorAnticoagulation and psychotropic medications.Use of anticonvulsants as prophylaxis for seizures in patients on clozapine.Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants.Acute oral toxicity of Polyalthia longifolia var. pendula leaf extract in Wistar albino rats.Carbamazepine-induced DRESS syndrome with recurrent fever and exanthema.Risperidone-induced reversible neutropenia.Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy.The Effect of Psychoactive Drugs on in vitro Platelet Function.Effect of micronutrients on behavior and mood in adults With ADHD: evidence from an 8-week open label trial with natural extension.The genotoxic and oxidative damage potential of olanzapine in vitro.DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder.Current issues in providing primary medical care to people with serious mental illness.Ecchymosis Due to Sertraline Use: A Case Report
P2860
Q28211440-D858C26C-27BF-43B1-9824-38362E2BDF89Q30440668-6EEB4417-9154-47C9-A6A6-592C5670CC40Q33415861-20E06237-8BE3-44AA-A407-E5E4F0C50FA3Q35018956-696B2997-1DF9-4AC3-A4DA-A52CD378806BQ36830355-2BEDBDF5-A3FA-4BDC-BD7E-80715FDAE86EQ37039855-7893769B-78FD-47C0-A72F-A612556D561BQ37160727-0AB42A3D-CC9A-41CF-9B36-94302A801DB7Q37169754-EA1FFB0B-D5FD-449B-A5A6-14EEF03E68C8Q37738383-236BC95A-1E6D-4D6E-AB0A-8041A84BE9F1Q38133450-F481DC10-C2CA-4E64-8D8D-A1A42A7A2D66Q38203303-EFF9028F-751F-4F8E-ADCE-979C335CADC8Q40279046-6B8F6902-0D31-4CAF-B5FC-2673A40642A3Q40543295-D2D5F946-A754-445F-83D8-C8E0BC2A858AQ41183689-0BDCA4EE-BBD1-4F1A-AD85-0399B8522F7DQ42117226-8206B854-3B38-4D90-8F79-7793E4346D65Q42365090-DC6B8BF4-BF48-4191-AF41-63920F63C548Q42645625-103A66DC-0416-4670-A40C-5A6CF6BC8172Q43027568-DA2799A9-FD41-4BC2-955D-E6EF7574DA5EQ47593705-BC303AD2-6D17-4478-8AD0-8C462C8940EAQ51913387-B6DDEAE2-A4CB-4CCA-8DE6-063F228DA1EBQ57493352-8AE4243F-781B-4255-A516-BCC447126478
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Hematologic side effects of psychotropics.
@ast
Hematologic side effects of psychotropics.
@en
type
label
Hematologic side effects of psychotropics.
@ast
Hematologic side effects of psychotropics.
@en
prefLabel
Hematologic side effects of psychotropics.
@ast
Hematologic side effects of psychotropics.
@en
P2093
P1433
P1476
Hematologic side effects of psychotropics.
@en
P2093
P304
P356
10.1016/S0033-3182(99)71206-5
P577
1999-09-01T00:00:00Z